Connect with us

INDUSTRIAL HEMP

Biogen Inc (NASDAQ:BIIB) Engages Mark Hernon As SVP, Chief Information Officer

Published

on

Biogen Inc (NASDAQ:BIIB) reported the appointment of Mr. Mark Hernon as SVP, Chief Information Officer. In his new role, Hernon will head the global information technology firm and be responsible for supporting and accelerating Biogen’s operations via delivery of unique technology capabilities, tools and systems that align with company’s corporate strategy.

The details

Hernon joins Biogen with experience of over 30 years in strategic and IT leadership. He was associated with Takeda Pharmaceuticals in recent years as the Regional CIO for the Americas & Global Head of R&D, HR and QA Systems, and Vice President of Operations at the Cambridge, MA location. Ms. Alexander expressed that with Hernon’s years in industry of successfully leading international operations and IT functions, they are extremely delighted to have him join them at Biogen.

His leadership and experience together with their current remarkable Biogen IT firm will enable Biogen to continue harnessing and creating information and data to lead new developments in neuroscience. Prior to Takeda, Hernon has been associated with Millennial Pharmaceuticals as CIO & VP Operations, heading strategic plans to streamline the firm, aligning with the business, and looking after the group’s transition.

Commenting on his new role, Hernon expressed that he is thrilled at the prospect of heading a team of dedicated and talented individuals focused on allowing Biogen’s plan via the smart application of technology.

Biogen marks as a leading firm in the segment of neuroscience. It discovers, develops and offers innovative therapies for people struggling with serious neurodegenerative and neurological diseases. Founded in 1978, today the company has the leading portfolio of drugs to treat multiple sclerosis; and has launched the first and only permitted treatment targeting spinal muscular atrophy.

In the last trading session, the stock price of Biogen gained 0.78% to close the day at $319.87. The gains came at a share volume of 915,577 compared to average share volume of 1.34 million.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement